Cargando…
Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer
Next‐generation sequencing (NGS) and digital PCR technologies allow analysis of the mutational profile of circulating cell‐free DNA (cfDNA) in individuals with advanced lung cancer. We have now evaluated the feasibility of cfDNA sequencing for mutation detection in patients with non‐small cell lung...
Autores principales: | Ohira, Tatsuo, Sakai, Kazuko, Matsubayashi, Jun, Kajiwara, Naohiro, Kakihana, Masatoshi, Hagiwara, Masaru, Hibi, Masaaki, Yoshida, Koichi, Maeda, Junichi, Ohtani, Keishi, Nagao, Toshitaka, Nishio, Kazuto, Ikeda, Norihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132294/ https://www.ncbi.nlm.nih.gov/pubmed/27575703 http://dx.doi.org/10.1111/cas.13068 |
Ejemplares similares
-
Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II–III
por: Kawaguchi, Yohei, et al.
Publicado: (2019) -
Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
por: Shimada, Yoshihisa, et al.
Publicado: (2021) -
Cytological differences between invasive and noninvasive or minimally invasive lung adenocarcinomas diagnosed in Japanese patients using needle biopsy specimens of pulmonary lesions ≤3 cm in diameter
por: Matsubayashi, Jun, et al.
Publicado: (2019) -
Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013) -
Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening
por: Suda, Kenichi, et al.
Publicado: (2023)